• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Pharma News

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News
  • Congress News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Pharma News

FDA approves pirtobrutinib for the treatment of advanced relapsed/refractory mantle cell lymph...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Advancements in thrombophilia testing: The role of multi-gene panels in venous thromboembolism
  • The role of UBTF-TD mutations in paediatric acute myeloid leukaemia and myelodysplastic syndrome
  • Desensitisation as treatment option in patients with drug hypersensitivity
  • HMB-001: Novel treatment for Glanzmann thrombasthenia
  • Anti-IL6 receptor antibody for the treatment of immune checkpoint-related hemophagocytic lymphohistiocytosis
  • Highlights from EBMT 2025
  • Journal scan
  • New haematology reimbursements in Belgium
Pharma News

Zanubrutinib receives FDA approval for patients with CLL or SLL

Read more
Pharma News

FDA accepts license application of reformulated denileukin diftitox for patients with CTCL

Read more
Pharma News

FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma

Read more
Pharma News

FDA’s priority review to quizartinib for FLT-3 mutant AML patients

Read more
Pharma News

FDA’s decision on gene therapy Roctavian for adults with haemophilia A in early 2023  

Read more
Pharma News

Axicabtagene ciloleucel receives European nod as second-line treatment for large B-cell lympho...

Read more
Pharma News

FDA grants priority review to novel haemophilia A treatment efanesoctocog alfa

Read more
Pharma News

European commission approves CAR T-cell therapy brexucabtagene autoleucel for treatment ALL

Read more
Previous 1 2 3 4 5 6 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025